Hanyu pharmaceutical has completed technical review and on-site inspection of enkephalin
-
Last Update: 2014-12-23
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Previously, Yuan Jiancheng, President of Hanyu pharmaceutical, said at the shareholders' meeting that the company's heavyweight new drug enkephalin will follow the academic marketing route after it goes on the market, and the gross profit rate of the product is roughly expected to be between 50% and 60% Public information shows that enkephalin injection has the effect of anti platelet aggregation It was first launched in the United States in 1998, and its sales amount in the United States in 2007 reached 332 million US dollars Hanyu pharmaceutical declared the clinical approval documents of enkephalin API and injection in October 2005, and was approved to carry out clinical trials in July 2006; in March 2010, the company applied for production, and was required to submit technical supplementary data for many times, so the approval time of the products was also delayed accordingly Hanyu pharmaceutical is the leader of polypeptide drugs in China The existing polypeptide drugs include thymopentin for injection, somatostatin for injection, deammopressin acetate injection and terlipressin for injection In 2013, the annual operating revenue was 301 million yuan, and the net profit attributable to the shareholders of the listed company was 130 million yuan.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
